Health Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021 July 1, 2021
Biotech Entasis Therapeutics Introduces ETX0462, a First-in-Class Candidate, Targeting Multidrug-Resistant Gram-Negative and Biothreat Pathogens July 1, 2021
Biotech Catalyst Biosciences to Host Research and Development Day on CB 4332 and Complement Programs July 1, 2021
Biotech Celsion GmbH Announces Commencement of Enrollment in Oxford University’s Phase 1 Study with ThermoDox® and Focused Ultrasound in Pancreatic Cancer July 1, 2021
Biotech Aileron Therapeutics Announces Initiation of Randomized, Double-Blind, Placebo-Controlled Trial of ALRN-6924 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) July 1, 2021
Cannabis Cartel Blue, Inc. Cartel, Inc. Announces Anticipated Legalization of Cannabis and Hemp Crops in Mexico Increases Production of Quality Hemp for its Premium Cigars and Accessories July 1, 2021
Cannabis Village Farms International’s Pure Sunfarms Receives Cannabis Cultivation License Amendment for Delta 2 Greenhouse, Increasing Production Capacity by 50% July 1, 2021
Biotech EyePoint Pharmaceuticals Announces New Category III CPT Code for DEXYCU® Intraocular Suspension, Approved by the American Medical Association July 1, 2021
Biotech Affimed Reports First Quarter 2021 Financial Results and Highlights Operational Progress July 1, 2021